1-855-378-42281-855-378-4228
One of the outpatient rehab alternatives for individuals in Hurst who are battling with opioid dependence and addiction is called opioid maintenance therapy. Licensed facilities and doctors are authorized to administer certain medications to opioid dependent people, many that are opioids also and are addiction. With low doses the client doesn't experience being high and also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first medication tried for this purpose, but there are alternative choices to choose from.
Methadone is an opioid and can be taken at an outpatient medical center certified to administer the med, that is taken on a daily basis in liquid or pill form. The cost of the med is approximately one hundred and fifty dolloars a month. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But different from Methadone that is only be administered in highly well-regulated medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is approximately three hundred dollars a month for the generic of the med. There is also a type of buprenorphine that contains naloxone, that is a med that blocks the effects of opiates. Someone consuming this version of the drug, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It is also taken every day, and is priced about $450 monthly. Naltrexone is an additional medication used in opioid maintenance therapy, but unlike the other drugs aforementioned it is an opioid blocker and is not an opiate. There is an option to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 /month.
For All Drug and Alcohol Rehab Programs In Hurst, Click Here.
